je.st
news
Cytokinetics, Inc. (CYTK) Downgraded to Hold at Zacks Investment Research
2016-01-05 05:44:42| Biotech - Topix.net
According to Zacks, "Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility.
Tags: research
hold
investment
downgraded
Category:Biotechnology and Pharmaceuticals